Cerebrovascular disease in the era of left ventricular assist devices with continuous flow: Risk factors, diagnosis, and treatment
- 31 May 2014
- journal article
- review article
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 33 (9), 878-887
- https://doi.org/10.1016/j.healun.2014.05.005
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse eventsThe Journal of Heart and Lung Transplantation, 2014
- Unexpected Abrupt Increase in Left Ventricular Assist Device ThrombosisThe New England Journal of Medicine, 2014
- Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist deviceThe Journal of Heart and Lung Transplantation, 2014
- The vexing problem of thrombosis in long-term mechanical circulatory supportThe Journal of Heart and Lung Transplantation, 2014
- An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trialThe Journal of Heart and Lung Transplantation, 2013
- Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patientsThe Journal of Heart and Lung Transplantation, 2013
- The Spectrum of Complications Following Left Ventricular Assist Device PlacementJournal of Cardiac Surgery, 2012
- Cerebrovascular complications of left ventricular assist devicesEuropean Journal of Cardio-Thoracic Surgery, 2012
- Cerebrovascular accidents in patients with a ventricular assist deviceThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureThe New England Journal of Medicine, 2001